Works matching IS 14628902 AND DT 2025 AND VI 27 AND IP 7


Results: 55
    1

    Front Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. C1, doi. 10.1111/dom.16537
    By:
    • Lala, Anuradha;
    • Levin, Adeera;
    • Khunti, Kamlesh
    Publication type:
    Article
    2
    3
    4
    5

    Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono‐ and combination therapy compared to gliclazide in overweight people with type 2 diabetes (RACELINES): A randomised, double‐blind trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. 3943, doi. 10.1111/dom.16431
    By:
    • van Baar, Michaël J. B.;
    • Muskiet, Marcel H. A.;
    • Scholtes, Rosalie A.;
    • Touw, Daan J.;
    • Nieuwdorp, Max;
    • Kramer, Mark H. H.;
    • Joles, Jaap A.;
    • Cherney, David Z. I.;
    • Bjornstad, Petter;
    • Krebber, Merle M.;
    • van Raalte, Daniël H.
    Publication type:
    Article
    7
    9
    10

    Social disadvantage and technology use among adults with type 1 diabetes in Quebec: A cross‐sectional study using data from the Canadian T1D (BETTER) Registry.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. 3921, doi. 10.1111/dom.16426
    By:
    • Khodabandehloo, Parisa;
    • Fakembe, Patience;
    • Senga, Joyeuse;
    • Shulman, Rayzel;
    • Lipscombe, Lorraine L.;
    • Witteman, Holly O.;
    • Banerjee, Ananya;
    • Presseau, Justin;
    • Nakhla, Meranda;
    • Dogba, Maman Joyce;
    • Lovblom, Leif Erik;
    • Rabasa‐Lhoret, Rémi;
    • Brazeau, Anne‐Sophie;
    • Najam, Adhiyat;
    • Cheema, Wajeeha;
    • MacGibbon, Christine;
    • Weisman, Alanna
    Publication type:
    Article
    11
    12
    13
    14
    15

    Proposed minimum requirements for market approval of continuous glucose monitoring (CGM) systems: A viewpoint from the IFCC working group on CGM.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. 4039, doi. 10.1111/dom.16420
    By:
    • Pleus, Stefan;
    • Eichenlaub, Manuel;
    • Eriksson Boija, Elisabet;
    • Diem, Peter;
    • Fokkert, Marion;
    • Hinzmann, Rolf;
    • Jendle, Johan;
    • Klonoff, David C.;
    • Makris, Konstantinos;
    • Nichols, James H.;
    • Pemberton, John;
    • Selvin, Elizabeth;
    • Slingerland, Robbert J.;
    • Thomas, Andreas;
    • Tran, Nam K.;
    • Witthauer, Lilian;
    • Freckmann, Guido
    Publication type:
    Article
    16

    Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18‐month follow‐up of a randomized clinical trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. 3891, doi. 10.1111/dom.16419
    By:
    • Caruso, Paola;
    • Maiorino, Maria Ida;
    • Longo, Miriam;
    • Maio, Antonietta;
    • Scappaticcio, Lorenzo;
    • Di Martino, Nicole;
    • Carbone, Carla;
    • Barrasso, Mariluce;
    • Caputo, Mariangela;
    • Gicchino, Maurizio;
    • Bellastella, Giuseppe;
    • Giugliano, Dario;
    • Esposito, Katherine
    Publication type:
    Article
    17
    18
    19

    Clinically meaningful improvements in treatment satisfaction in insulin‐naïve people with type 2 diabetes post initiation of insulin glargine 300 U/mL: A post hoc analysis of real‐world ATOS study.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. 4011, doi. 10.1111/dom.16415
    By:
    • Snoek, Frank;
    • Galstyan, Gagik;
    • Khan, Niaz;
    • Tirosh, Amir;
    • Kesavadev, Jothydev;
    • Vargas‐Uricoechea, Hernando;
    • Baghous, Houssem;
    • Mabunay, Maria Aileen;
    • Grulovic, Natasa;
    • Corp dit Genti, Valerie;
    • Msihid, Jerome;
    • Harris, Stewart
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50